Prednisolone sodium phosphate and Cetirizine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisolone sodium phosphate (prednisolone sodium phosphate) and Cetirizine hydrochloride (cetirizine hydrochloride). Common drug interactions include foetal death among females and cardio-respiratory arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Prednisolone sodium phosphate and Cetirizine hydrochloride. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisolone sodium phosphate?

Prednisolone sodium phosphate has active ingredients of prednisolone sodium phosphate. It is often used in ulcerative colitis. eHealthMe is studying from 2,310 Prednisolone sodium phosphate users. Check the latest studies of Prednisolone sodium phosphate.

What is Cetirizine hydrochloride?

Cetirizine hydrochloride has active ingredients of cetirizine hydrochloride. It is often used in allergies. eHealthMe is studying from 34,908 Cetirizine hydrochloride users. Check the latest studies of Cetirizine hydrochloride.



On Jul, 06, 2026

23 people who take Prednisolone sodium phosphate and Cetirizine hydrochloride together, and have interactions are studied.

Prednisolone sodium phosphate and Cetirizine hydrochloride drug interactions.

What are the common drug interactions of Prednisolone Sodium Phosphate and Cetirizine Hydrochloride, by gender? *:

female:

  1. Foetal death (death of foetus)
  2. Fatigue (feeling of tiredness)
  3. Rash
  4. Back pain
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  6. Coeliac disease (simple food intolerance)
  7. Constipation
  8. Drug hypersensitivity
  9. Drug ineffective
  10. Drug intolerance (drug sensitivity)

male:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Increased upper airway secretion
  3. Post procedural complication
  4. Vocal cord paralysis
  5. Disability
  6. Vitamin d deficiency
  7. Poor venous access
  8. Pyrexia (fever)
  9. Oral candidiasis (fungal infection of mouth)
  10. Pneumonia

What are the common drug interactions of Prednisolone Sodium Phosphate and Cetirizine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

  1. Deafness neurosensory
  2. Hyperreflexia (overactive or over responsive reflexes)
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Strabismus (a disorder in which the two eyes do not line up in the same direction)

2-9:

n/a

10-19:

  1. Chest pain
  2. Confusional state
  3. Cough
  4. Dehydration (dryness resulting from the removal of water)
  5. Fatigue (feeling of tiredness)
  6. Infectious mononucleosis (infection usually caused by the epstein-barr virus)
  7. Inflammation
  8. Lethargy (tiredness)
  9. Memory impairment
  10. Muscular weakness (muscle weakness)

20-29:

n/a

30-39:

  1. Foetal death (death of foetus)
  2. Pyrexia (fever)
  3. Back pain
  4. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  5. Coeliac disease (simple food intolerance)
  6. Constipation
  7. Drug hypersensitivity
  8. Drug ineffective
  9. Drug intolerance (drug sensitivity)
  10. Erythema (redness of the skin)

40-49:

n/a

50-59:

n/a

60+:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  3. Blood bilirubin increased
  4. Blood cholesterol increased
  5. Dizziness
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Oedema peripheral (superficial swelling)
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Weight increased

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 34.78%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 26.09%
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 26.09%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 26.09%
  5. Pain: 4 people, 17.39%
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 13.04%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.70%
  8. Hypersensitivity: 2 people, 8.70%
  9. Herpes Zoster: 2 people, 8.70%
  10. Drowsiness: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone sodium phosphate and Cetirizine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prednisolone sodium phosphate and Cetirizine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisolone sodium phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cetirizine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prednisolone sodium phosphate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cetirizine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone sodium phosphate and cetirizine hydrochloride (the active ingredients of Prednisolone sodium phosphate and Cetirizine hydrochloride, respectively), and Prednisolone sodium phosphate and Cetirizine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: